title: Complement-mediated lipopolysaccharide release and outer membrane damage in Escherichia coli J5: requirement for C9.
abstract: Lipopolysaccharides (LPS) are major antigenic components of the outer membrane of Gram-negative bacteria and can stimulate activation of the complement system. Such activation leads to formation of the complement membrane attack complex (MAC) on the cell walls, LPS release and, in serum-sensitive strains, to cell death. In this study, Escherichia coli J5 strains, which incorporate exogenous galactose exclusively into LPS, were used to generate target strains with different LPS chemotypes, and the LPS of the strains was labelled with tritium (3H-LPS). The ability of normal human serum (NHS) and human complement-deficient sera to release LPS was subsequently monitored. NHS-induced release of 64-95.7% of 3H-LPS within 30 min; overall, no significant difference was observed between release of LPS from E. coli J5 strains with different LPS chemotypes. In functional assays, maximum LPS release had occurred by 30 min and before maximum bacterial killing. Electron microscopy revealed NHS-induced outer-membrane disruption in the form of blebs at 15 min; at this time-point the inner membrane remained intact. Background LPS release and no bactericidal activity were detected in heat-inactivated serum or human sera deficient in C6, C7 or C8. The C9-deficient (C9D) serum had low bactericidal activity and failed to induce LPS release; however, addition of purified human C9 reconstituted its ability to release LPS. This study demonstrated the need for functional C9 molecules for LPS-releasing activities in serum-sensitive E. coli J5 strains.
authors: Department of Microbiology, National University of Ireland, Galway, Ireland.
authors: A M
authors: AM
authors: O'Hara
authors: A P
authors: AP
authors: Moran
authors: R
authors: R
authors: Würzner
authors: A
authors: A
authors: Orren
mesh_terms: D001770:Blood Bactericidal Activity / Q000276:immunology; D002462:Cell Membrane / Q000648:ultrastructure; D003186:Complement C9 / Q000276:immunology*; D004926:Escherichia coli / Q000276:immunology* / Q000378:metabolism / Q000648:ultrastructure; D005690:Galactose / Q000378:metabolism; D006801:Humans; D008070:Lipopolysaccharides / Q000378:metabolism*; D008854:Microscopy, Electron
chemical_list: D003186:Complement C9; D008070:Lipopolysaccharides; D005690:Galactose